Dashboard
Manage Tickers

GILD GILEAD SCIENCES, INC.

Nasdaq gilead.com


$ 119.69 $ 1.35 (1.14 %)    

Friday, 31-Oct-2025 16:15:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 119.79
$ 116.06
$ 114.50 x 1
$ 121.99 x 200
$ 114.02 - $ 121.91
$ 83.59 - $ 124.61
10,030,185
na
148.64B
$ 0.47
$ 23.55
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-28-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-04-2023 06-30-2023 10-Q
10 05-03-2023 03-31-2023 10-Q
11 02-22-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-23-2022 12-31-2021 10-K
16 11-03-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 02-26-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 02-27-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-07-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 02-27-2017 12-31-2016 10-K
36 11-07-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 02-24-2016 12-31-2015 10-K
40 11-04-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-overweight-on-gilead-sciences-raises-price-target-to-145
Wells Fargo Maintains Overweight on Gilead...
10/31/2025 21:12:51

Wells Fargo analyst Mohit Bansal maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from ...

jp-morgan-maintains-overweight-on-gilead-sciences-raises-price-target-to-150
JP Morgan Maintains Overweight on Gilead S...
10/31/2025 18:36:06

JP Morgan analyst Chris Schott maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $1...

gileads-hiv-drugs-power-earnings-beat-company-eyes-multiple-launches-by-2026
Gilead's HIV Drugs Power Earnings Beat, Co...
10/31/2025 17:41:12

Gilead beats estimates, raises 2025 guidance, driven by strong HIV and liver drug sales and multiple launches planned for 2026.

nasdaq-100-rebounds-amazon-jumps-10-on-strong-earnings-whats-moving-markets-friday
Nasdaq 100 Rebounds, Amazon Jumps 10% On S...
10/31/2025 17:26:36

Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap gi...

rbc-capital-maintains-sector-perform-on-gilead-sciences-raises-price-target-to-105
RBC Capital Maintains Sector Perform on Gi...
10/31/2025 14:57:23

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and raises the price target...

cantor-fitzgerald-reiterates-overweight-on-gilead-sciences-maintains-135-price-target
Cantor Fitzgerald Reiterates Overweight on...
10/31/2025 13:36:40

Cantor Fitzgerald analyst Carter Gould reiterates Gilead Sciences (NASDAQ:GILD) with a Overweight and maintains $135 price t...

needham-reiterates-buy-on-gilead-sciences-maintains-133-price-target
Needham Reiterates Buy on Gilead Sciences,...
10/31/2025 12:13:03

Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:GILD) with a Buy and maintains $133 price target.

gilead-sciences-raises-fy2025-adj-eps-guidance-from-795-825-to-805-825-vs-803-est-raises-fy2025-sales-guidance-from-28300b-28700b-to-28400b-28700b-vs-28842b-est
Gilead Sciences Raises FY2025 Adj EPS Guid...
10/30/2025 20:05:04

GILEAD SCIENCES, INC.RECONCILIATION OF GAAP TO NON-GAAP 2025 FULL-YEAR GUIDANCE(1)(unaudited)         (in millions, except perc...

gilead-sciences-raises-fy2025-gaap-eps-guidance-from-585-615-to-665-685-vs-598-est
Gilead Sciences Raises FY2025 GAAP EPS Gui...
10/30/2025 20:03:40

GILEAD SCIENCES, INC.RECONCILIATION OF GAAP TO NON-GAAP 2025 FULL-YEAR GUIDANCE(1)(unaudited)         (in millions, except perc...

gilead-sciences-q3-adj-eps-247-beats-213-estimate-sales-7769b-beat-7446b-estimate
Gilead Sciences Q3 Adj. EPS $2.47 Beats $2...
10/30/2025 20:02:34

Gilead Sciences (NASDAQ:GILD) reported quarterly earnings of $2.47 per share which beat the analyst consensus estimate of $2.13...

meta-tumbles-10-google-marks-historic-rally-whats-moving-markets-thursday
Meta Tumbles 10%, Google Marks Historic Ra...
10/30/2025 17:40:46

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...

earnings-scheduled-for-october-30-2025
Earnings Scheduled For October 30, 2025
10/30/2025 11:12:06

cvs-health-delivers-confident-outlook-after-q3-performance-stock-hits-52-week-high
CVS Health Delivers Confident Outlook Afte...
10/29/2025 14:20:39

CVS Health topped Q3 estimates with $102.9 billion in revenue and raised its 2025 EPS outlook to up to $6.65 amid strong segmen...

a-glimpse-of-gilead-sciencess-earnings-potential
A Glimpse of Gilead Sciences's Earnings Po...
10/29/2025 14:04:23

update-fda-approves-kite-pharmas-yescarta-bla-supplement-allowing-short-term--80c-storage-for-up-to-90-days-at-authorized-treatment-centers-supplement-approval-was-on-october-21-2025
UPDATE: FDA Approves Kite Pharma's Yescart...
10/28/2025 15:46:08

https://www.fda.gov/media/189364/download?attachment

fda-approves-kites-yescarta-for-treatment-of-adults-with-large-b-cell-lymphoma-that-is-refractory-to-first-line-chemoimmunotherapy
FDA Approves Kite's Yescarta For Treatment...
10/28/2025 15:19:56

-Reuters

if-you-invested-1000-in-gilead-sciences-stock-20-years-ago-you-would-have-this-much-today
If You Invested $1000 In Gilead Sciences S...
10/27/2025 14:45:17

retail-investors-top-stocks-with-earnings-this-week-sofi-apple-meta-and-more
Retail Investors' Top Stocks With Earnings...
10/27/2025 14:38:22

Investors are gearing up for a jam-packed week of earnings featuring several big tech names and retail-trader favorites. 

td-cowen-maintains-buy-on-gilead-sciences-raises-price-target-to-125
TD Cowen Maintains Buy on Gilead Sciences,...
10/23/2025 15:31:32

TD Cowen analyst Tyler Van Buren maintains Gilead Sciences (NASDAQ:GILD) with a Buy and raises the price target from $115 to...

gilead-sciences-to-present-new-research-reinforcing-commitment-to-advancing-innovation-for-people-living-with-liver-disease-at-the-liver-meeting-2025
Gilead Sciences To Present New Research Re...
10/23/2025 12:05:43

- Late-Breaking Real-World Experience of People Switching from Obeticholic Acid to Livdelzi® to be Presented atThe Liver Meetin...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION